Non-hodgkin Lymphoma

CLINICAL_TRIALS trial_result · 2020-11-13

Clinical Trial Update: Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]

Clinical study evaluating CAR-T cells targeting CD19 and CD22 for relapsed or refractory B cell non-Hodgkin lymphoma; status not provided.

CLINICAL_TRIALS trial_result · 2020-11-03

Clinical Trial Update: T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies [Phase 1, Phase 2]

A clinical trial update for T-cells expressing anti-CD19 CAR in pediatric and young adult patients with B-cell malignancies across Phase 1 a…

CLINICAL_TRIALS trial_result · 2020-10-19

Clinical Trial Update: A Study for Patients With Non-Hodgkin's Lymphomas [Phase 2]

Phase 2 trial update for a study in non-Hodgkin's lymphomas has completed with results posted.

CLINICAL_TRIALS trial_result · 2020-10-05

Clinical Trial Update: Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas [Phase 2]

Phase IIa trial evaluating redirected autologous T cells engineered with anti-CD19 attached to TCRz and 4-signaling domains in CD19+ B-cell …

CLINICAL_TRIALS trial_result · 2020-09-10

Clinical Trial Update: Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases [Phase 2]

Phase 2 trial evaluating myeloablative umbilical cord blood transplantation in various hematological diseases has completed with results pos…

CLINICAL_TRIALS trial_result · 2020-08-31

Clinical Trial Update: Zevalin-beam for Aggressive Lymphoma [Phase 3]

Phase 3 trial update for Zevalin-beam in aggressive non-Hodgkin's lymphoma has completed with results posted.

CLINICAL_TRIALS trial_result · 2020-08-31

Clinical Trial Update: Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma [Phase 1]

Phase 1 trial of anti-CD19 white blood cells in children and young adults with B-cell leukemia or lymphoma completed; results posted in 2020…

CLINICAL_TRIALS trial_result · 2020-08-18

Clinical Trial Update: Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab [Phase 3]

Phase 3 trial comparing ABP798 to rituximab in non-Hodgkin lymphoma has completed with results posted.

CLINICAL_TRIALS trial_result · 2020-08-14

Clinical Trial Update: Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma [Phase 1, Phase 2]

A phase 1/2 trial evaluating pembrolizumab plus lenalidomide in relapsed Hodgkin and non-Hodgkin lymphoma was terminated with results posted…

CLINICAL_TRIALS trial_result · 2020-08-11

Clinical Trial Update: BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) [Phase 1]

A Phase 1 dose-escalation trial of BI 836826 in patients with relapsed or refractory non-Hodgkin lymphoma has completed with results posted.

CLINICAL_TRIALS trial_result · 2020-08-10

Clinical Trial Update: A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. [Phase 2]

Phase 2 trial update for an oral LY317615 in relapsed or refractory diffuse large B-cell lymphoma, with completed status and results posted.

CLINICAL_TRIALS trial_result · 2020-07-28

Clinical Trial Update: MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin [Phase 1, Phase 2]

Clinical trial update for MG4101 plus rituximab with lymphodepletion in relapsed/refractory non-Hodgkin lymphoma (B-cell origin) spanning Ph…

CLINICAL_TRIALS trial_result · 2020-07-14

Clinical Trial Update: Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Phase 2]

Phase 2 trial evaluating autologous peripheral stem cell transplant in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma has comple…

CLINICAL_TRIALS trial_result · 2020-07-08

Clinical Trial Update: Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas [Phase 2]

Phase 2 clinical trial assessing chemotherapy plus ofatumumab followed by G-CSF for mobilizing peripheral blood stem cells in patients with …

CLINICAL_TRIALS trial_result · 2020-06-26

Clinical Trial Update: P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies [Phase 3]

Phase 3 trial of umbilical cord blood cells expanded with MPCs for transplantation in hematologic malignancies has completed.

CLINICAL_TRIALS trial_result · 2020-06-02

Clinical Trial Update: Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger [Phase 2]

Phase 2 trial comparing Rituximab-HCVAD alternating with Rituximab-Methotrexate-Cytarabine vs Rituximab-CHOP in newly diagnosed high-risk ag…

CLINICAL_TRIALS trial_result · 2020-05-18

Clinical Trial Update: Meloxicam vs Placebo for Mobilization [Phase 2]

Phase 2 trial comparing Meloxicam to placebo for mobilization in hematologic malignancies has completed with results posted.

CLINICAL_TRIALS trial_result · 2020-05-11

Clinical Trial Update: Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma [Phase 2]

Phase 2 clinical trial evaluating lenalidomide with rituximab in non-Hodgkin lymphoma has completed.

CLINICAL_TRIALS trial_result · 2020-05-07

Clinical Trial Update: Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia [Phase 2]

Phase 2 safety and tolerability study of PCI-32765 in various B-cell malignancies completed; results posted.

CLINICAL_TRIALS trial_result · 2020-04-29

Clinical Trial Update: A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants [Phase 1, Phase 2]

Phase 1/2 study of idasanutlin in combination with obinutuzumab for relapsed/refractory follicular lymphoma and with rituximab for relapsed/…

CLINICAL_TRIALS trial_result · 2020-04-21

Clinical Trial Update: Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR [NA]

Clinical trial update on donor-derived humoral immunity and hematopoietic stem cell transplantation completed with posted results in 2020.

CLINICAL_TRIALS trial_result · 2020-04-13

Clinical Trial Update: Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) [Phase 1]

Phase 1 study of ADCT-402 in relapsed or refractory B-cell lineage non-Hodgkin lymphoma completed; results posted in 2020.

CLINICAL_TRIALS trial_result · 2020-04-09

Clinical Trial Update: Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment [Phase 2]

Phase 2 trial update of combination chemotherapy in Hodgkin's disease or non-Hodgkin lymphoma not responding to prior treatment.

CLINICAL_TRIALS trial_result · 2020-04-07

Clinical Trial Update: Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor [Phase 1, Phase 2]

A phase 1/2 clinical trial evaluating chidamide in combination with decitabine for relapsed/refractory non-Hodgkin lymphoma.

CLINICAL_TRIALS trial_result · 2020-03-24

Clinical Trial Update: Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide [Phase 1, Phase 2]

Phase I/II study evaluating bendamustine in combination with ofatumumab, carboplatin, and etoposide in non-Hodgkin lymphoma has completed wi…

Top drugs studied for this disease